PDCD1LG2 and classic Hodgkin lymphoma: Later (2016), in a cohort of 118 cHL cases, the frequency of genetic structural alterations involving the PD-L1 and PD-L2 genes (e.g., polysomy, gene copy gains, and translocations) was reported at similar rates comparing EBV-positive and EBV-negative tumors [51].